Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Under Section 503B, outsourcing facilities may not compound drugs that are essentially copies of one or more approved drug products, and they are prohibited from compounding using bulk drug substances unless the substance appears on FDA's 503B bulks list or the drug appears on FDA's drug shortagel at the time of compounding, distribution and dispensing
Five providers charge the same at every dose with no commitment: Mochi and Eden at $199, ReflexMD at $297, OrderlyMeds at $299, and Fridays at $198 on the annual term
Community research plans now often model subcutaneous amounts, but no approved clinical protocol or published human pharmacokinetic study has established those subcutaneous amounts
Bhasin A, et al
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
